Legend Biotech Corporation logo
Legend Biotech Corporation LEGN
$ 34.06 0.12%

Annual report 2023
added 12-14-2024

report update icon

Legend Biotech Corporation Balance Sheet 2011-2024 | LEGN

Annual Balance Sheet Legend Biotech Corporation

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - - -206 M - - - - - - -

Long Term Debt

- - - - - - - - - - - - -

Long Term Debt Current

3.18 M 3.56 M 911 K 1.46 M 1.03 M - - - - - - - -

Total Non Current Liabilities

- - - 280 M 283 M 261 M - - - - - - -

Total Current Liabilities

- - - - - - - - - - - - -

Total Liabilities

597 M 587 M 354 M 124 M 411 M 420 M - - - - - - -

Deferred Revenue

- - - 55.3 M 46.3 M 40.3 M - - - - - - -

Retained Earnings

- - - - - - - - - - - - -

Total Assets

1.85 B 1.33 B 1.12 B 722 M 288 M 429 M - - - - - - -

Cash and Cash Equivalents

1.28 B 786 M 689 M 456 M 83.4 M 210 M - - - - - - -

Book Value

1.25 B 744 M 766 M 598 M -123 M 8.65 M - - - - - - -

Total Shareholders Equity

- - - 280 M -123 M 8.65 M - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Legend Biotech Corporation

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - 1.59 M - 1.62 M - 1.91 M - - - 5.06 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - 367 M - 274 M - 280 M - - - 283 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- - - - 647 M - 535 M - 441 M - - - 411 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

- - - - 471 M - 340 M - 280 M - 401 M - -123 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

- - - - 1.12 B - 875 M - 721 M - - - 288 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

- - - - 689 M - 488 M - 456 M - 562 M - 83.4 M - - - 210 M - - - 2.12 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

- - - - 471 M - 340 M - 280 M - - - -123 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

- - - - 471 M - 340 M - 280 M - 401 M - -123 M - - - 8.65 M - - - 12.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency